Literature DB >> 27657667

Rebuttal from Dr. Mino-Kenudson.

Mari Mino-Kenudson1.   

Abstract

Year:  2016        PMID： 27657667      PMCID： PMC5009077          DOI： 10.21037/tlcr.2016.08.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  16 in total

1.  BEAMing up for detection and quantification of rare sequence variants.

Authors:  Meng Li; Frank Diehl; Devin Dressman; Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Methods       Date:  2006-02       Impact factor: 28.547

Review 2.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

3.  Detection and quantification of mutations in the plasma of patients with colorectal tumors.

Authors:  Frank Diehl; Meng Li; Devin Dressman; Yiping He; Dong Shen; Steve Szabo; Luis A Diaz; Steven N Goodman; Kerstin A David; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

4.  Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.

Authors:  Lynette M Sholl; Dara L Aisner; Marileila Varella-Garcia; Lynne D Berry; Dora Dias-Santagata; Ignacio I Wistuba; Heidi Chen; Junya Fujimoto; Kelly Kugler; Wilbur A Franklin; A John Iafrate; Marc Ladanyi; Mark G Kris; Bruce E Johnson; Paul A Bunn; John D Minna; David J Kwiatkowski
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

5.  MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.

Authors:  Santosh Patnaik; Reema Mallick; Eric Kannisto; Rohit Sharma; Wiam Bshara; Sai Yendamuri; Samjot Singh Dhillon
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

6.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

7.  Plasma T790M Result Alters Treatment Options in a Previously T790 Wild-Type EGFR-Mutant Lung Cancer.

Authors:  Zofia Piotrowska; Benjamin Drapkin; Jeffrey A Engelman; Rebecca J Nagy; Richard B Lanman; Lecia V Sequist
Journal:  J Thorac Oncol       Date:  2016-04-12       Impact factor: 15.609

Review 8.  Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.

Authors:  Jie Luo; Li Shen; Di Zheng
Journal:  Sci Rep       Date:  2014-09-09       Impact factor: 4.379

9.  Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.

Authors:  Stephen Q Wong; Jason Li; Angela Y-C Tan; Ravikiran Vedururu; Jia-Min B Pang; Hongdo Do; Jason Ellul; Ken Doig; Anthony Bell; Grant A MacArthur; Stephen B Fox; David M Thomas; Andrew Fellowes; John P Parisot; Alexander Dobrovic
Journal:  BMC Med Genomics       Date:  2014-05-13       Impact factor: 3.063

10.  Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.

Authors:  Qiang Pu; Yuchuan Huang; Yanrong Lu; Yong Peng; Jie Zhang; Guanglin Feng; Changguo Wang; Lunxu Liu; Ya Dai
Journal:  Thorac Cancer       Date:  2016-02-01       Impact factor: 3.500
View more
  2 in total

1.  Commentary on tumor heterogeneity.

Authors:  Helmut H Popper
Journal:  Transl Lung Cancer Res       Date:  2016-08

2.  Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center.

Authors:  Min Joon Lee; Katrina Hueniken; Nathan Kuehne; Lin Lu; Shirley Xue Jiang; Badr Id Said; Alex McCartney; Yizhuo Gao; Mindy Liang; Tamara Obuobi; Hadas Sorotsky; Lawson Eng; M Catherine Brown; Wei Xu; Geoffrey Liu
Journal:  Cancer Manag Res       Date:  2020-02-13       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.